MGX vs GRNA

Comparison between Metagenomi Inc (MGX, Company) and GreenLight Biosciences Inc (GRNA, Company).

MGX vs GRNA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MGX(COMPANY)	GRNA(COMPANY)
Market Cap	$45M	$45M
Max Drawdown	90.69%	98.70%
Sharpe Ratio	0.08	-1.27
5Y Beta	1.00	N/A
Industry	Biotechnology	N/A
P/E Ratio	-0.53	-1.59
PEG Ratio	-0.05	N/A
Debt to Equity	0.00%	112.33%
P/S Ratio	N/A	4.39
P/B Ratio	N/A	2.07

Market Cap

MGX

$45M

Winner

GRNA

$45M

Max Drawdown

Winner

MGX

90.69%

GRNA

98.70%

Sharpe Ratio

Winner

MGX

0.08

GRNA

-1.27

5Y Beta

MGX

1.00

GRNA

N/A

Industry

MGX

Biotechnology

GRNA

N/A

P/E Ratio

MGX

-0.53

Winner

GRNA

-1.59

PEG Ratio

MGX

-0.05

GRNA

N/A

Debt to Equity

Winner

MGX

0.00%

GRNA

112.33%

P/S Ratio

MGX

N/A

GRNA

4.39

P/B Ratio

MGX

N/A

GRNA

2.07

MGX vs GRNA - Historical Returns

Returns include dividend reinvestment.

Period	MGX	GRNA
1 month	-11.11%	+0.84%
3 months	-12.41%	+42.28%
6 months	-31.03%	-59.61%
1 year	-22.08%	-92.34%
Max(CAGR)	-59.63%	-89.56%

MGX

-11.11%

Winner

GRNA

+0.84%

MGX

-12.41%

Winner

GRNA

+42.28%

Winner

MGX

-31.03%

GRNA

-59.61%

Winner

MGX

-22.08%

GRNA

-92.34%

Max(CAGR)

Winner

MGX

-59.63%

GRNA

-89.56%

MGX vs GRNA - Annual Returns (2022 - 2026)

Returns include dividend reinvestment.

Year	MGX	GRNA
2026	-28.14%	N/A
2025	-57.26%	N/A
2024	-64.99%	N/A
2023	N/A	-73.96%
2022	N/A	-87.44%

MGX vs GRNA Drawdown Comparison

The maximum drawdown for MGX was -90.69%, occurring on Jun 16, 2026. This drawdown has not yet recovered.

The maximum drawdown for GRNA was -98.70%, occurring on May 24, 2023. This drawdown has not yet recovered.

The current MGX drawdown is -90.20%. The current GRNA drawdown is -97.79%.

Rank	MGX	GRNA
#1	-90.69% Feb 14, 2024 - Jun 16, 2026	-98.70% Mar 21, 2022 - May 24, 2023
#2	N/A	-47.65% Feb 3, 2022 - Mar 10, 2022
#3	N/A	-11.72% Mar 11, 2022 - Mar 15, 2022
#4	N/A	-0.30% Mar 15, 2022 - Mar 17, 2022